Aqua Bio Technology ASA: Disclosure of large shareholdings

16 Mar 2026 07:30 CET

Reference is made to the stock exchange notice from Aqua Bio Technology ASA
("ABTEC" or the "Company") published on 13 March 2026 regarding the
Extraordinary General Meeting approving a NOK 50 million debt conversion with
the issuance of 10,000,000 new shares (the "New Shares") in the Company, at a
subscription price of NOK 5.00 per New Share (the "Debt Conversion").

The following shareholders of the Company have, on 14 March 2026, been
allocated New Shares in the Debt Conversion which implies that their holdings
have surpassed a notifiable threshold:

· Forza NO AS has been allocated 2,716,216 New Shares in the Debt Conversion.
Following this and upon completion of the Debt Conversion, Forza NO AS will
hold 3,096,473 shares in the Company, corresponding to 20.3% of the shares and
votes in the Company; and
· Terabyte Holding AS, a company controlled by ABTEC board member Terje Blytt,
has been allocated 2,310,811 New Shares in the Debt Conversion. Following this
and upon completion of the Debt Conversion, Terabyte Holding AS will hold
2,638,211 shares in the Company, corresponding to 17.3% of the shares and
votes in the Company; and
· Expo Holding AS, a company controlled by Martin Siem, has been allocated
1,891,892 New Shares in the Debt Conversion. Following this and upon
completion of the Debt Conversion, Martin Siem and associated companies will
hold 2,253,187 shares in the Company, corresponding to 14.8% of the shares and
votes in the Company; and
· Norlane AS, a company controlled by ABTEC chairman Roger Sedal, has been
allocated 1,662,162 New Shares in the Debt Conversion. Following this and upon
completion of the Debt Conversion, Norlane AS will hold 1,828,368 shares in
the Company, corresponding to 12.0% of the shares and votes in the Company;
and
· Dank I Halden AS has been allocated 1,418,919 New Shares in the Debt
Conversion. Following this and upon completion of the Debt Conversion, Dank I
Halden AS will hold 1,617,572 shares in the Company, corresponding to 10.6% of
the shares and votes in the Company.

The following shareholders have had their holdings diluted as a consequence of
the Debt Conversion, and thereby surpassed a notifiable threshold:

· Following completion of the Debt Conversion, RH Industri AS and Roger
Hofseth will hold 464,355 shares in the Company, corresponding to 3.0% of the
shares and votes in the Company; and
· Following completion of the Debt Conversion, Intelco AS and Øystein Tvenge
will hold 419,491 shares in the Company, corresponding to 2.8% of the shares
and votes in the Company; and
· Following completion of the Debt Conversion, PJUR Eiendom AS will hold
418,269 shares in the Company, corresponding to 2.7% of the shares and votes
in the Company.

The calculations in this notice are based on a total number of shares in the
Company of 15,227,935 following completion of the Debt Conversion, and
registration of the shares in the Norwegian Register of Business Enterprises.

This disclosure is made pursuant to section 4-2 of the Norwegian Securities
Trading Act.

Contacts
Kristian Flaten
CEO & CFO
Aqua Bio Technology ASA

Phone: +47 9509 2322
Email: kf@aquabiotech.no

About Us
Aqua Bio Technology ASA (ABTEC) is a technology and distribution group in
skincare and nonfood. The group has distribution towards B2C and B2B, and
offers freight, customs, and logistics services. The group also develops
sustainable biotechnology for use in skincare products. Aqua Bio Technology is
listed on Euronext Expand Oslo.

This notice is published by Kristian Flaten on the listed date and time.

This information has been submitted pursuant to the Securities Trading Act §
5-12 and MAR. The information was submitted for publication, through the
agency of the contact persons set out above, at 2026-03-16 07:30 CET.

More information:
Access the news on Oslo Bors NewsWeb site

668358_Aqua Bio Technology ASA- Disclosure of large shareholdings.pdf